Cutler Group LP Ventyx Biosciences, Inc. Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Jan 18, 2024	SELL	$2.08 - $31.18 $208 - $3,118	-100 Reduced 20.0%	400 $0
Q3 2023 Nov 07, 2023	BUY	$29.8 - $40.3 $11,920 - $16,119	400 Added 400.0%	500 $2,000
Q2 2023 Jul 18, 2023	SELL	$28.53 - $39.55 $79,884 - $110,739	-2,800 Reduced 96.55%	100 $0
Q1 2023 May 01, 2023	BUY	$29.51 - $46.65 $64,922 - $102,630	2,200 Added 314.29%	2,900 $3,000
Q4 2022 Feb 07, 2023	SELL	$24.16 - $36.38 $24,160 - $36,380	-1,000 Reduced 58.82%	700 $2,000
Q3 2022 Oct 25, 2022	BUY	$12.64 - $38.7 $21,488 - $65,790	1,700 New	1,700 $2,000

125

52.9M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $105M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.